Verve Therapeutics Inc (VERV)
4.52
-0.03
(-0.66%)
USD |
NASDAQ |
Nov 21, 11:19
Verve Therapeutics Price: 4.52 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 4.84 | 4.84 | 4.48 | 4.55 | 1.448M |
| Nov 19, 2024 | 4.49 | 4.925 | 4.49 | 4.84 | 3.167M |
| Nov 18, 2024 | 4.85 | 4.92 | 4.48 | 4.50 | 2.253M |
| Nov 15, 2024 | 5.44 | 5.44 | 4.78 | 4.79 | 1.876M |
| Nov 14, 2024 | 5.75 | 5.83 | 5.37 | 5.38 | 1.786M |
| Nov 13, 2024 | 6.51 | 6.68 | 5.78 | 5.79 | 1.194M |
| Nov 12, 2024 | 6.33 | 6.495 | 6.205 | 6.41 | 1.241M |
| Nov 11, 2024 | 6.43 | 6.75 | 6.26 | 6.42 | 5.335M |
| Nov 08, 2024 | 6.36 | 6.39 | 6.15 | 6.31 | 749914.0 |
| Nov 07, 2024 | 6.41 | 6.64 | 6.02 | 6.36 | 1.318M |
| Nov 06, 2024 | 6.45 | 6.81 | 6.28 | 6.41 | 1.477M |
| Nov 05, 2024 | 6.19 | 6.77 | 6.135 | 6.38 | 1.567M |
| Nov 04, 2024 | 5.95 | 6.165 | 5.62 | 6.05 | 920724.0 |
| Nov 01, 2024 | 5.73 | 5.955 | 5.65 | 5.93 | 1.158M |
| Oct 31, 2024 | 5.77 | 5.83 | 5.62 | 5.73 | 1.085M |
| Oct 30, 2024 | 5.92 | 6.14 | 5.675 | 5.79 | 1.242M |
| Oct 29, 2024 | 5.95 | 6.18 | 5.88 | 5.99 | 1.276M |
| Oct 28, 2024 | 6.01 | 6.45 | 5.93 | 5.94 | 1.344M |
| Oct 25, 2024 | 5.72 | 6.091 | 5.72 | 5.97 | 1.238M |
| Oct 24, 2024 | 5.54 | 6.02 | 5.45 | 5.72 | 1.241M |
| Oct 23, 2024 | 5.67 | 5.710 | 5.42 | 5.54 | 1.023M |
| Oct 22, 2024 | 5.52 | 5.71 | 5.30 | 5.69 | 744741.0 |
| Oct 21, 2024 | 5.65 | 5.679 | 5.44 | 5.55 | 470457.0 |
| Oct 18, 2024 | 5.47 | 5.735 | 5.39 | 5.65 | 586458.0 |
| Oct 17, 2024 | 5.57 | 5.60 | 5.30 | 5.46 | 990603.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.40
Minimum
Aug 14 2024
73.99
Maximum
Sep 10 2021
22.12
Average
17.54
Median
Aug 08 2023
Price Benchmarks
| Ardelyx Inc | 4.97 |
| Biomarin Pharmaceutical Inc | 62.35 |
| Sage Therapeutics Inc | 4.96 |
| ALX Oncology Holdings Inc | 1.225 |
| Immuneering Corp | 2.17 |
Price Related Metrics
| PS Ratio | 15.47 |
| Price to Book Value | 0.7525 |
| Earnings Yield | -54.42% |
| Market Cap | 382.68M |